Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Tax Provisions (2021 - 2026)

MoonLake Immunotherapeutics' Tax Provisions history spans 6 years, with the latest figure at $622000.0 for Q1 2026.

  • Quarterly Tax Provisions rose 306.54% to $622000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Mar 2026, up 195.89% year-over-year, with the annual reading at $611000.0 for FY2025, 116.67% up from the prior year.
  • Tax Provisions came in at $622000.0 for Q1 2026, up from $248000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $622000.0 in Q1 2026 to a low of $7332.0 in Q1 2022.
  • The 5-year median for Tax Provisions is $43920.0 (2023), against an average of $96786.4.
  • The largest YoY upside for Tax Provisions was 678.4% in 2024 against a maximum downside of 6.65% in 2024.
  • MoonLake Immunotherapeutics' Tax Provisions stood at $11012.0 in 2022, then surged by 298.84% to $43920.0 in 2023, then decreased by 6.65% to $41000.0 in 2024, then skyrocketed by 504.88% to $248000.0 in 2025, then surged by 150.81% to $622000.0 in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Tax Provisions are $622000.0 (Q1 2026), $248000.0 (Q4 2025), and $115000.0 (Q3 2025).